Top stories in gastroenterology: Cannabinoid hyperemesis syndrome common, cannabinoids contain anti-inflammatory effect

Among the top stories in gastroenterology is a report that cannabinoid hyperemesis syndrome, a condition experienced by chronic marijuana users, might be more common than previously believed. A meta-analysis showed that cannabinoids have an anti-inflammatory effect in the gut, warranting further research that could yield new therapies for inflammatory bowel disease. Other stories include a study showing that IBS has been linked to certain DNA variants found only in women, patients who undergo elective stoma reversal are at increased risk of C. difficile, and a list of 10 recent advances in IBS research as IBS Awareness Month comes to an end.

Cannabinoid hyperemesis syndrome: What GIs should know

Cannabinoid hyperemesis syndrome is a condition experienced by chronic marijuana users who develop symptoms including nausea, vomiting and abdominal pain, which are characteristically relieved by hot showers. Read More.

Early data warrants human studies of cannabinoids for IBD

Many preclinical studies have shown cannabinoids have anti-inflammatory effects in the gut, which warrants further research that could lead to the development of new therapies for inflammatory bowel disease, according to a meta-analysis published in Inflammatory Bowel Diseases. Read More.

IBS linked to genetic variant found only in women

In a genome-wide association study, investigators linked irritable bowel syndrome to certain DNA variants found only in women, which researchers said could explain why the condition is less common in men. Read More.

C. difficile risk increased in patients who undergo stoma reversal

Patients who undergo elective stoma reversal are at higher risk for postoperative Clostridium difficile infection than patients who undergo elective colectomy, according to new research published in Diseases of the Colon & Rectum. Read More.

IBS Awareness Month: 10 recent advances in research, diagnostics

April is IBS Awareness Month. First designated by the International Foundation for Functional Gastrointestinal Disorders in 1997, this initiative aims to raise awareness of the 10% to 15% of Americans who experience the symptoms of irritable bowel syndrome, an “often misunderstood and stigmatized condition,” according to the IFFGD. Read More.